Skip to main content
TipRanks
Go Ultimate75% OFF

Mark Ahn Insider Profile

4 Followers

Mark Ahn, Director at Abeona Therapeutics, holds 493.18K shares in Abeona Therapeutics (Ticker: ABEO), holds 116.22K shares in SELLAS Life Sciences Group (Ticker: SLS), holds 1.24M shares in Talon Therapeutics Inc (Ticker: TLON).

Mark Ahn's Trading History

ABEO
Abeona Therapeutics
Nov 09, 2016DirectorUninformative Buy346.50K$1.19M
SLS
SELLAS Life Sciences Group
Jul 02, 2014President & CEO, DirectorUninformative Buy6.40K$913.53K
TLON
Talon Therapeutics Inc
――――

You May Also Like

Mark Ahn insider profile FAQ

What is the percentage of profitable transactions made by Mark Ahn?
The percentage of profitable transactions made by Mark Ahn is 33%.
What is the average return per transaction made by Mark Ahn?
The average return per transaction made by Mark Ahn is 0.60%.
What stocks does Mark Ahn hold?
Mark Ahn holds: ABEO, SLS, TLON stocks.
What was Mark Ahn’s latest transaction?
Mark Ahn’s latest transaction was an Uninformative Buy of $346.50K.
What was Mark Ahn's most profitable transaction?
Mark Ahn’s most profitable transaction was an Informative Sell of SLS stock on January 29, 2014. The return on the trade was 69.10%.
What is Mark Ahn's role in Abeona Therapeutics?
Mark Ahn's role in Abeona Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.